/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Intrinsiqq's two-stage DCF values Quipt Home Medical (QIPT) at about $8.43 per share, or $6.33 with a 25% margin of safety. Every assumption is adjustable below; this is analysis, not investment advice.
Intrinsiqq's two-stage discounted cash flow (DCF) model estimates an intrinsic value of about $8.43 per share for QIPT. It projects recent free cash flow forward at a growth rate that fades toward a long-run rate, then discounts those cash flows back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $6.33. The output moves with the growth and discount-rate inputs, so it is best read as a range, not a single number. You can change every assumption with the sliders on this tab.
The base case grows QIPT's free cash flow at about 2.0% a year before fading, against roughly -4.1% historical free-cash-flow growth. If the price implies growth well above what the company has actually delivered, the market is paying for optimism; if below, expectations are modest. Adjust the growth assumption on this tab to see what the current price is really betting on.
A margin of safety is the discount to intrinsic value you demand before buying, to protect against being wrong on the inputs. Intrinsiqq applies 25% by default, which turns QIPT's $8.43 intrinsic estimate into a $6.33 entry. Wider margins suit less predictable businesses; you can set your own on this tab. This is analysis from SEC filings, not investment advice.
SourceFair value computed from the 10-Q filed 9 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 13 Jun 2026. How this is calculated.
Fiscal year ends Sep.